Bright Minds Biosciences

📍 New York, United States👥 9 employees💰 Last funded 2022
Bright Minds Biosciences is clinical-stage biotech company developing novel serotonergic drugs for the treatment of epilepsy, depression and other CNS disorders
1
Total investors
0
Early stage
0
Mid stage
0
Late stage
Founded
Investor geography1 country
United Kingdom
1
Frequently asked questions
Who invested in Bright Minds Biosciences?
Bright Minds Biosciences has 1 investors on record on gritt.io.
When did Bright Minds Biosciences last raise funding?
The most recent investment in Bright Minds Biosciences recorded on gritt.io was in 2022.
What industry is Bright Minds Biosciences in?
Bright Minds Biosciences operates in Biotechnology Research. Find similar Biotechnology Research investors on gritt.io.
Where is Bright Minds Biosciences based?
Bright Minds Biosciences is headquartered in New York, United States.